IV vs. IA TPA in Acute Ischemic Stroke with CT Angiographic Evidence of Major Vessel Occlusion: A Feasibility Study
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Background and Aims
Studies suggest that stroke patients with thrombus in a major cerebral vessel respond less favorably to intravenous (IV) thrombolysis. The purpose of this study was to test the feasibility of a protocol comparing IV versus intra-arterial (IA) recombinant tissue plasminogen activator (TPA) in an acute ischemic stroke with major vessel occlusion.
Consecutive ischemic stroke patients presenting <3 h from symptom onset with major vessel occlusion on CT angiogram (CTA) were randomly assigned to IV TPA (per NINDS protocol) or IA TPA (22 mg over 2 h). Demographics, times to presentation and thrombolysis, presenting NIH stroke scale (NIHSS) and 90-day NIHSS, Barthel Index, and modified Rankin Scale were recorded. CT-scans at 24-h were reviewed for presence of hemorrhage. Recanalization was determined by post-procedure MR angiograms, which are obtained the day after thrombolytic therapy.
Seven patients (median NIHSS = 16) were randomized to IV (N = 4) or IA (N = 3) TPA. There were no significant differences in the presentation NIHSS, time to presentation, or time to treatment between the two groups. Hemorrhage was noted in one patient in the IA group (asymptomatic) and one patient in the IV group (symptomatic). Recanalization was seen in all patients treated with IA TPA and none treated with IV TPA (P = 0.03, Fisher’s Exact test).
We found that it is feasible to conduct a trial comparing IV vs. IA TPA in ischemic stroke patients with major vessel occlusion presenting <3 h from onset. Patients treated with IA TPA showed a trend toward higher rate of recanalization. A larger trial may be designed to test safety and effectiveness of IA TPA in this specific group of stroke patients.
- Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med 333: pp. 1581-1587 CrossRef
- Hacke, W, Kaste, M, Bluhmki, E, Brozman, M, Dávalos, A, Guidetti, D, Larrue, V, Lees, KR, Medeghri, Z, Machnig, T, Schneider, D, Kummer, R, Wahlgren, N, Toni, D (2008) Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 359: pp. 1317-1329 CrossRef
- Furlan, A, Higashida, R, Wechsler, L, Gent, M, Rowley, H, Kase, C, Pessin, M, Ahuja, A, Callahan, F, Clark, WM, Silver, F, Rivera, F (1999) Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA 282: pp. 2003-2011 CrossRef
- Adams, HP, del Zoppo, G, Alberts, MJ, Bhatt, DL, Brass, L, Furlan, A, Grubb, RL, Higashida, RT, Jauch, EC, Kidwell, C, Lyden, PD, Morgenstern, LB, Qureshi, AI, Rosenwasser, RH, Scott, PA, Wijdicks, EF (2007) Guidelines for the early management of adults with ischemic stroke. Stroke 38: pp. 1655-1711 CrossRef
- Lisboa, RC, Jovanovic, BD, Alberts, MJ (2002) Analysis of the safety and efficacy of intra-arterial thrombolytic therapy in ischemic stroke. Stroke 33: pp. 2866-2871 CrossRef
- Lev, MH, Farkas, J, Rodriguez, VR, Schwamm, LH, Hunter, GJ, Putman, CM, Rordorf, GA, Buonanno, FS, Budzik, R, Koroshetz, WJ, Gonzalez, RG (2001) CT angiography in the rapid triage of patients with hyperacute stroke to intraarterial thrombolysis: accuracy in the detection of large vessel thrombus. J Comput Assist Tomogr 25: pp. 520-528 CrossRef
- Combined intravenous and intra-arterial recanalization for acute ischemic stroke: the Interventional Management of Stroke Study. Stroke 35: pp. 904-911 CrossRef
- Ciccone, A, Valvassori, L, Gasparotti, R, Scomazzoni, F, Ballabio, E, Sterzi, R (2007) Debunking 7 myths that hamper the realization of randomized controlled trials on intra-arterial thrombolysis for acute ischemic stroke. Stroke 38: pp. 2191-2195 CrossRef
- Bookstein, JJ, Bookstein, FL (2000) Augmented experimental pulse-spray thrombolysis with tissue plasminogen activator, enabling dose reduction by one or more orders of magnitude. J Vasc Interv Radiol 11: pp. 299-303 CrossRef
- Phase I findings. N Engl J Med 312: pp. 932-936
- Neumann-Haefelin, T, Rochemont, R, Fiebach, JB, Gass, A, Nolte, C, Kucinski, T, Rother, J, Siebler, M, Singer, OC, Szabo, K, Villringer, A, Schellinger, PD (2004) Effect of incomplete (spontaneous and postthrombolytic) recanalization after middle cerebral artery occlusion: a magnetic resonance imaging study. Stroke 35: pp. 109-114 CrossRef
- Bastianello, S, Pierallini, A, Colonnese, C, Brughitta, G, Angeloni, U, Antonelli, M, Fantozzi, LM (1991) Fieschi, Bozzao L. Hyperdense middle cerebral artery CT sign. Neuroradiology 33: pp. 207-211 CrossRef
- Moulin, T, Cattin, F, Crépin-Leblond, T, Tatu, L, Chavot, D, Piotin, M, Viel, JF, Rumbach, L, Bonneville, JF (1996) Early CT signs in acute middle cerebral artery infarction: Predictive value for subsequent infarct locations and outcome. Neurology 47: pp. 366-375
- Zorzon, M, Mase, G, Pozzi-Mucelli, F, Biasutti, E, Antonutti, L, Iona, L, Cazzato, G (1993) Increased density in the middle cerebral artery by nonenhanced computed tomography: Prognostic value in acute cerebral infarction. Eur Neurol 33: pp. 256-259 CrossRef
- Launes, J, Ketonen, L (1987) Dense middle cerebral artery sign: an indicator of poor outcome in middle cerebral artery area infarction. J Neurol Neurosurg Psychiatry 50: pp. 1550-1552 CrossRef
- Manelfe, C, Larrue, V, Kummer, R, Bozzao, L, Ringleb, P, Bastianello, S, Iweins, F, Lasaffre, E (1999) Association of hyperdense middle cerebral artery sign with clinical outcome in patients with tissue plasminogen activator. Stroke 30: pp. 769-772
- Tomsick, T, Brott, T, Barsan, W, Broderick, J, Clarke Haley, E, Spilker, J, Khoury, J (1996) Prognostic value of the hyperdense middle cerebral artery sign and stroke scale score before ultraearly thrombolytic therapy. AJNR Am J Neuroradiol 17: pp. 79-85
- Generalized efficacy of rtPA for acute stroke: subgroup analysis of the NINDS rtPA stroke trial. Stroke 28: pp. 2119-2125
- Qureshi, AI (2004) Endovascular treatment of cerebrovascular diseases and intracranial neoplasms. Lancet 363: pp. 804-813 CrossRef
- Agarwal, P, Kumar, S, Hariharan, S, Eshkar, N, Verro, P, Cohen, B, Sen, S (2004) Hyperdense middle cerebral artery sign: can it be used to select intraarterial versus intravenous thrombolysis in acute ischemic stroke?. Cerebrovasc Dis 17: pp. 182-190 CrossRef
- Garg, N, Eshkar, N, Tanenbaum, L, Cohen, B, Sen, S (2004) Computed tomography angiographic correlates of early computed tomography signs in acute ischemic stroke. J Neuroimaging 14: pp. 242-245 CrossRef
- http://clinicaltrials.gov/ct2/show/NCT00640367?term=synthesis&rank=10. Accessed December 27, 2008.
- http://www.neurorad-bern.ch/combatstroke/. Accessed December 27, 2008.
- Macleod, MR, Davis, SM, Mitchell, PJ, Gerraty, RP, Fitt, G, Hankey, GJ, Stewart-Wynne, EG, Rosen, D, McNeil, JJ, Bladin, CF, Chambers, BR, Herkes, GK, Young, D, Donnan, GA (2005) Results of a multicentre, randomised controlled trial of intra-arterial urokinase in the treatment of acute posterior circulation ischaemic stroke. Cerebrovasc Dis 20: pp. 12-17 CrossRef
- Broderick, JP (1998) Practical considerations in the early treatment of ischemic stroke. Am Fam Physician 57: pp. 73-79
- Mattle, HP, Arnold, M, Georgiadis, D, Baumann, C, Nedeltchev, K, Benninger, D, Remonda, L, Büdingen, C, Diana, A, Pangalu, A, Schroth, G, Baumgartner, RW (2008) Comparison of intraarterial and intravenous thrombolysis for ischemic stroke with hyperdense middle cerebral artery sign. Stroke 39: pp. 379-383 CrossRef
- Rha, JH, Saver, JL (2007) The impact of recanalization on ischemic stroke ourcome, a meta-analysis. Stroke 38: pp. 967-973 CrossRef
- IV vs. IA TPA in Acute Ischemic Stroke with CT Angiographic Evidence of Major Vessel Occlusion: A Feasibility Study
Volume 11, Issue 1 , pp 76-81
- Cover Date
- Print ISSN
- Online ISSN
- Humana Press Inc
- Additional Links
- CT angiogram
- Industry Sectors
- Author Affiliations
- 1. UNC Stroke Center, Department of Neurology, University of North Carolina, 7001 NC Neuroscience Hospital, CB#7025, Chapel Hill, NC, 27599-7025, USA
- 2. University of California Davis, Sacramento, CA, USA
- 3. Department of Radiology, University of North Carolina, Chapel Hill, NC, USA